全文获取类型
收费全文 | 6144篇 |
免费 | 451篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 134篇 |
妇产科学 | 138篇 |
基础医学 | 1120篇 |
口腔科学 | 120篇 |
临床医学 | 525篇 |
内科学 | 1573篇 |
皮肤病学 | 182篇 |
神经病学 | 606篇 |
特种医学 | 91篇 |
外科学 | 576篇 |
综合类 | 26篇 |
一般理论 | 3篇 |
预防医学 | 472篇 |
眼科学 | 83篇 |
药学 | 483篇 |
中国医学 | 21篇 |
肿瘤学 | 442篇 |
出版年
2024年 | 10篇 |
2023年 | 106篇 |
2022年 | 272篇 |
2021年 | 413篇 |
2020年 | 196篇 |
2019年 | 269篇 |
2018年 | 287篇 |
2017年 | 185篇 |
2016年 | 226篇 |
2015年 | 229篇 |
2014年 | 308篇 |
2013年 | 349篇 |
2012年 | 499篇 |
2011年 | 524篇 |
2010年 | 276篇 |
2009年 | 234篇 |
2008年 | 364篇 |
2007年 | 358篇 |
2006年 | 317篇 |
2005年 | 305篇 |
2004年 | 241篇 |
2003年 | 224篇 |
2002年 | 199篇 |
2001年 | 25篇 |
2000年 | 14篇 |
1999年 | 36篇 |
1998年 | 29篇 |
1997年 | 22篇 |
1996年 | 14篇 |
1995年 | 11篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 9篇 |
1991年 | 8篇 |
1990年 | 9篇 |
1989年 | 4篇 |
1987年 | 7篇 |
1986年 | 3篇 |
1983年 | 3篇 |
1979年 | 8篇 |
1977年 | 4篇 |
1975年 | 3篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1969年 | 3篇 |
1968年 | 3篇 |
1966年 | 2篇 |
1965年 | 3篇 |
排序方式: 共有6646条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
Rydz Natalia Leggo Jayne Tinlin Shawn James Paula Lillicrap David 《American journal of hematology》2013,88(12):1030-1034
A reference genotyping laboratory was established in 2000 at Queen's University, Kingston, to provide genetic testing for Hemophilia A (HA) and B (HB) and create a Canadian mutation database. Canadian hemophilia treatment centers and genetics clinics provided DNA and clinical information from November 2000 to March 2011. The factor VIII (F8) gene was analyzed in 1,177 patients (47% of HA population) and 787 female family members and the factor IX (F9) gene in 267 patients (47% of HB population) and 123 female family members, using Southern Blot, PCR, conformation sensitive gel electrophoresis, and/or direct sequencing. The mutation detection rates for HA and HB were 91% and 94%, respectively. 380 different F8 mutations were identified: inversions of intron 22 and intron 1, 229 missense, 45 nonsense, eight deletions, 70 frameshifts, 25 splice site, and one compound mutation with a splice site and intron 1 inversion. Of these mutations, 228 were novel to the Hemophilia A Database (HADB, http://hadb.org.uk/ ). A total 125 different F9 mutations were identified: 80 missense, 12 frameshift, 12 splice site, nine nonsense and seven promoter mutations, three large deletions, and two compound mutations with both missense and nonsense changes. Of these mutations, 36 were novel to the International Haemophilia B Mutation database ( http://www.kcl.ac.uk/ip/petergreen/haemBdatabase.html ). The Canadian F8 and F9 mutation database reflects the allelic heterogeneity of HA and HB, and is similar to previously described populations. This report represents the largest and longest duration experience of a national hemophilia genotyping program documented, to date. Am. J. Hematol. 88:1030–1034, 2013. © 2013 Wiley Periodicals, Inc. 相似文献
95.
Ferdane Kutlar Yoram Unguru Natalia Dixon Niren Patel Lakiea Bailey Lina Zhuang 《Hemoglobin》2014,38(3):207-210
Of the 1570 reported hemoglobin (Hb) variants detected to date, 390 are α2-globin chain (some variants have yet to be identified by DNA analyses and are therefore presumed) and 827 are the result of mutations of the β-globin chain. Due to their location on the Hb structure, only a minority of these variants result in a clinical phenotype; most are silent and are detected during routine surveillance, are found incidentally during other disease-related investigations or following newborn screening programs. In this report we discuss phenotype/genotype and molecular characteristics of two new Hb variants, both of which were clinically silent. One is an α2-globin chain variant located at codon 3 [α3(A1)Ser→Tyr; HBA2: c.11C?>?A] named Hb Tallahassee and the other is a β-globin chain variant located at codon 119 [β119(GH2)Gly→Ser; HBB: c.358G?>?A] called Hb Madison-NC. 相似文献
96.
Natalia Podzolkova Tetiana Tatarchuk Aikerm Doshchanova Gulsara Eshimbetova 《Gynecological endocrinology》2016,32(3):246-249
Dydrogesterone is an oral retroprogesterone widely used to treat progesterone deficiencies, including irregular menstrual cycles (MCs). This prospective, non-interventional, single-arm, post-marketing, observational study evaluated the effects of dydrogesterone on MC regularization. Women aged 18–40 years who had been prescribed dydrogesterone to treat irregular MCs due to progesterone deficiency were enrolled across 64 centers in Russia, Ukraine, Kazakhstan and Uzbekistan. Study objectives included: patients reporting ≥1 regular MC during treatment; the number of regular MCs after the end of treatment over a 6-month follow-up (FU) period. In total, 996 women were enrolled. Of those who completed treatment, 946/955 patients (99.1%) achieved ≥1 regular MC. During FU, 680/860 patients (79.1%) maintained ≥6 regular MCs. Patient grading of menstrual pain and anxiety decreased significantly during treatment (p?≤?0.0001 versus baseline); this persisted during FU. Dydrogesterone was associated with high or very high patient satisfaction (856/955; 89.6%); the clinical response was considered good or excellent in 819/955 patients (85.8%). In total, 16/986 patients (1.6%) reported an adverse event (AE); two had serious AEs (SAEs) (unrelated to treatment) and three discontinued treatment due to non-SAEs. Dydrogesterone therapy was effective in achieving MC regularization and reducing menstrual pain and anxiety, during both treatment and 6-month FU. 相似文献
97.
98.
Predictive factors for anemia response to erythropoiesis‐stimulating agents in myelofibrosis 下载免费PDF全文
Juan‐Carlos Hernández‐Boluda Juan‐Gonzalo Correa Regina García‐Delgado Joaquín Martínez‐López Alberto Alvarez‐Larrán María‐Laura Fox Valentín García‐Gutiérrez Manuel Pérez‐Encinas Francisca Ferrer‐Marín María‐Isabel Mata‐Vázquez José‐María Raya Natalia Estrada Silvia García Ana Kerguelen María‐Antonia Durán Manuel Albors Francisco Cervantes 《European journal of haematology》2017,98(4):407-414
99.
Tetiana Kiriazova Karsten Lunze Anita Raj Natalia Bushara Elena Blokhina Evgeny Krupitsky 《AIDS care》2017,29(5):559-563
Many HIV-positive people who inject drugs (PWID) globally are not receiving HIV care. This represents a major challenge among key populations to end the global HIV epidemic. This qualitative study explored the process and associated barriers of linking HIV-positive PWID who are in addiction treatment to HIV care in St. Petersburg, Russia. We conducted three focus groups and seven semi-structured interviews with participants in the LINC (“Linking Infectious and Narcology Care”) project at addiction and HIV hospitals in St. Petersburg. The sample consisted of 25 HIV-infected patients with opioid dependence and seven health-care providers, including addiction and infectious disease physicians and case managers. A variety of intertwining factors influence effective engagement of PWID with HIV treatment. Stigma, problematic patient–provider relationships, and fragmented health care were the main challenges for HIV care initiation by PWID, which were further exacerbated by injection drug use. Effective linkage of PWID to HIV care requires acknowledging and addressing stigma’s role and different perspectives of patients and providers. 相似文献
100.